Insider Trading July 1, 2026 05:51 PM

Marvell Technology Executive Chris Koopmans Executes $2.82 Million Stock Sale Under 10b5-1 Plan

President and COO's transaction occurs amid significant stock appreciation and broader semiconductor sector momentum.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
MRVL

Marvell Technology President and COO Chris Koopmans executed a sale of 10,000 shares on July 1, 2026, valued at $2,819,200. The transaction was conducted under a pre-arranged 10b5-1 trading plan established in January 2026. This sale follows a substantial 258% increase in Marvell's stock price over the past year, with the company currently valued at $239.5 billion. The transaction highlights ongoing executive activity within the semiconductor sector, which has experienced significant gains driven by data center demand.

Marvell Technology Executive Chris Koopmans Executes $2.82 Million Stock Sale Under 10b5-1 Plan
MRVL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Marvell Technology President and COO Chris Koopmans sold 10,000 shares valued at $2,819,200 on July 1, 2026, under a pre-arranged 10b5-1 trading plan established in January 2026.
  • Marvell's stock has surged 258% over the past year, with a current market capitalization of $239.5 billion, though valuation metrics suggest the stock may be overvalued relative to its Fair Value.
  • Analyst sentiment remains positive with UBS and B.Riley raising price targets, citing expanding opportunities in CXL technology and Marvell's partnership with Nvidia, amid broader gains in the Philadelphia chip index driven by data center demand.

Marvell Technology President and COO Chris Koopmans executed a transaction involving the sale of 10,000 shares of the company’s common stock on July 1, 2026. The total value of this sale was recorded at $2,819,200. The shares were divested at prices fluctuating between $279.46 and $283.70 per share. This specific transaction was carried out in accordance with a pre-arranged 10b5-1 trading plan that Mr. Koopmans established on January 5, 2026.

The timing of this sale occurs against a backdrop of significant appreciation for Marvell’s stock, which has surged 258% over the past year. At the time of the transaction, shares were trading at $271.95, contributing to a market capitalization of $239.5 billion. Valuation metrics from InvestingPro analysis suggest the stock may be overvalued relative to its Fair Value, currently trading at a P/E ratio of 95.62. Investors seeking comprehensive valuation metrics and additional ProTips for MRVL can access this data on the platform.

These shares were held indirectly through the Christopher R. Koopmans and Heather J. Koopmans Family Trust. Following this divestment, Mr. Koopmans retains a position of 227,754 shares of Marvell Technology (NASDAQ:MRVL) common stock. This remaining holding includes 362 shares that were purchased through the company’s Employee Stock Purchase Plan on June 5, 2026.

Parallel to this executive activity, Marvell Technology announced a quarterly dividend of $0.06 per share. This dividend is payable on July 30, 2026, to stockholders of record as of July 10, 2026. Analyst sentiment remains positive, with UBS raising its price target for Marvell Technology to $340 from $230, maintaining a Buy rating. UBS cited an expanding opportunity in CXL technology as a key driver for this upgrade. Similarly, B.Riley increased its price target for Marvell to $345 from $240, also with a Buy rating, following Marvell’s partnership with Nvidia. Marvell has reaffirmed its second-quarter fiscal 2027 guidance, adding stability to its financial outlook.

Further reinforcing the positive outlook, UBS raised its financial estimates for Marvell, highlighting the potential growth in CXL technology. These developments occur amid a broader surge in the Philadelphia chip index, which has seen significant gains due to demand for data center chips. Additionally, the company announced that Dan Durn will take over as CFO on June 15, succeeding Willem Meintjes.

The current market environment for Marvell Technology reflects these dynamics. The stock is listed at $271.95, reflecting a decrease of $25.94 or -8.71% during the closed session at 15:59:59 in USD. In after-hours trading, the stock showed a movement to $273.60, an increase of $1.55 or +0.57% at 17:53:05. This data is visualized through a chart created with Highcharts 11.4.8, covering timeframes from 1D to Max, with price points ranging from 270 to 290.

For investors evaluating whether MRVL represents a bargain, the fastest way to determine this is through the Fair Value calculator. This tool utilizes a mix of 17 proven industry valuation models for maximum accuracy. Investors can obtain the bottom line for MRVL plus thousands of other stocks to find hidden gems with massive upside.

Risks

  • Valuation concerns are present, with InvestingPro analysis indicating the stock appears overvalued relative to its Fair Value, trading at a P/E ratio of 95.62.
  • Executive sales activity, while executed under a pre-arranged plan, may signal internal profit-taking following a significant 258% stock appreciation over the past year.
  • Market volatility is evident, with the stock showing a -8.71% decline during the closed session, highlighting potential short-term price fluctuations despite long-term growth narratives.

More from Insider Trading

MediaAlpha Director Nonko Liquidates $427K in MAX Shares Amid Rally Jul 1, 2026 CoreWeave Executive McBee Brannin Sells $5.47M in Stock Amid Market Shifts Jul 1, 2026 Westwood Holdings Director Emerita Susan Byrne Executes $53,882 Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Trupanion COO John Gallagher Executes Pre-Arranged Stock Sale Amid Valuation Debate Jul 1, 2026 Contineum Therapeutics CEO Executes Stock Transactions Under 10b5-1 Plan Jul 1, 2026